Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-CD26 monoclonal antibody BT 5/9 for steroid-refractory graft-versus-host disease
2007-005809-21Phase 2Active
- Sponsor
- Fondazione Ricerca Trapianto di Midollo Osseo
- Start
- Mar 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of begelomab in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Fondazione Ricerca Trapianto di Midollo Osseo. Started Mar 2009; status: active.
02
Drugs
begelomab
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on 2007-005809-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005809-21.